The Surprising Background of Cancer Immunotherapy for Dogs

Immunocidin is an immunotherapy drug consisting of bacterial cell wall components and bacterial DNA. It is a potent immune system modulator and also has direct anti-tumor properties. Originally approved by the USDA for treating mammary tumors in canine patients, some veterinarians are starting to use the therapy to help patients with different types of cancer. Graeme McRae, one of the inventors of Immunocidin and the head of Novavive, the company that manufactures Immunocidin, shares how the drug was originally developed and what they've learned while helping dogs with cancer. 🐾 More about Immunocidin and clinical studies here: https://www.ccralliance.org/post/immu... The Canine Cancer Alliance (CCA) is a 501(c)3 nonprofit foundation led by volunteers. CCA funds research seeking cancer prevention and cures for our beloved pets. Research and clinical trials supported by CCA are paving the way for safer, more effective, and affordable treatments that are available for all pets. 🐾 Learn more here https://www.ccralliance.org/ -------Support Life-Saving Research CCA-funded research and educational programs are 100% supported by donations ❤️Donate here https://givebutter.com/CCAUnleashHope 🐾Start a Facebook Fundraiser:   / caninecanceralliance   🐶Start a Fundraiser in honor of your beloved pet https://givebutter.com/tributetails 🚗Consider donating a vehicle https://www.ccralliance.org/donate-a-..."